Vascular leak syndrome and serositis as an unusual manifestation of chronic graft-versus-host disease in nonmyeloablative transplants [2]

Bone Marrow Transplantation

Volumn 35, Issue 2, 2005, Pages 201-203

  Gyger, M ^a   Rosenberg, A ^a   Shamy, A ^a   Hercz, A ^a   Caplan, S ^a   Sebag, I A ^a   Brisson, M L ^a   Roy, D C ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; FLUDARABINE; INTERLEUKIN 2; MELPHALAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANASARCA; ANOREXIA; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CAPILLARY LEAK SYNDROME; CASE REPORT; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; CYTOKINE RELEASE; DYSPNEA; ECHOCARDIOGRAPHY; EOSINOPHILIA; FEMALE; GRAFT VERSUS LEUKEMIA EFFECT; HEART SIZE; HEART TAMPONADE; HELPER CELL; HUMAN; IMMUNOBIOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LEG SWELLING; LETTER; MULTIPLE MYELOMA; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE; THORAX RADIOGRAPHY; TREATMENT OUTCOME; WEIGHT REDUCTION; WHOLE BODY RADIATION;

CAPILLARY LEAK SYNDROME; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; SEROSITIS; TRANSPLANTATION CONDITIONING;

EID: 13244275035     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704730     Document Type: Letter

References (10)

1. McSweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390-3400.
2. Mielcarek M, Martin P, Leisenring W et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003; 102: 756-762.
3. Higman MA, Vogelsang GB. Chronic graft-versus-host disease. Br J Haematol 2004; 125: 435-454.
4. Amoura Z, Papo T, Ninet J et al. Systemic capillary leak syndrome: report of 13 patients with special focus on course and treatment. Am J Med 1997; 103: 514-519.
5. Silberstein L, Davies A, Kelsey S et al. Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as a manifestation of chronic-graft-versus-host disease after nonmyeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion. Bone Marrow Transplant 2001; 27: 231-233.
6. Gyger M, Baron C, Forest L et al. Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-versus-host disease. Exp Hematol 1998; 26: 426-434.
7. Storb R, Yu C, Wagner JL et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmalogical immunosuppression after marrow transplantation. Blood 1997; 89: 3048-3054.
8. Shlomchick WD. Antigen presentation in graft-versus-host disease. Exp Hematol 2003; 31: 1187-1197.
9. Merad M, Hoffmann P, Ranheim E et al. Depletion of host langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nature Med 2004; 10: 510-517.
10. Gleichman E, Pals ST, Rolink AG et al. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunology Today 1984; 5: 324-332.